Oxford Nanopore Technologies (ONT) Competitors GBX 208.20 -2.80 (-1.33%) As of 08/22/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONT vs. BTG, ABC, GNS, ERGO, OXB, SLN, PRTC, HZD, FARN, and VRPShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. Its Competitors BTG Abcam Genus Ergomed Oxford Biomedica Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Oxford Nanopore Technologies (LON:ONT) and BTG (LON:BTG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability. Is ONT or BTG more profitable? BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Oxford Nanopore Technologies-94.82% -26.02% -14.42% BTG N/A N/A N/A Which has preferable valuation & earnings, ONT or BTG? BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford Nanopore Technologies£184.78M10.69-£175.21M-£18.58-11.21BTG£914.10M0.00N/A£28.50N/A Do analysts recommend ONT or BTG? Oxford Nanopore Technologies currently has a consensus target price of GBX 232.50, indicating a potential upside of 11.67%. Given Oxford Nanopore Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe Oxford Nanopore Technologies is more favorable than BTG.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00BTG 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in ONT or BTG? 38.4% of Oxford Nanopore Technologies shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor ONT or BTG? In the previous week, BTG had 6 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 6 mentions for BTG and 0 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 1.69 beat BTG's score of 0.00 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media. Company Overall Sentiment Oxford Nanopore Technologies Very Positive BTG Neutral SummaryBTG beats Oxford Nanopore Technologies on 7 of the 13 factors compared between the two stocks. Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.98B£137.17M£5.82B£3.22BDividend YieldN/A3.74%4.40%5.04%P/E Ratio-11.213.8731.30164.70Price / Sales10.694,053.60455.29310,111.42Price / Cash4.0413.1938.0227.93Price / Book3.1046.309.535.91Net Income-£175.21M-£90.99M£3.26B£5.89B7 Day Performance-1.09%0.64%2.13%49.52%1 Month Performance4.01%2.73%3.21%56.91%1 Year Performance70.94%203.46%30.18%140.38% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore Technologies1.7828 of 5 starsGBX 208.20-1.3%GBX 232.50+11.7%+72.0%£1.98B£184.78M-11.211,281Positive NewsBTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus0.5692 of 5 starsGBX 2,654.10+1.7%GBX 2,650-0.2%+55.1%£1.74B£666.67M220.00480News CoverageAnalyst ForecastERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.5798 of 5 starsGBX 500flatGBX 410.33-17.9%+53.2%£531.51M£98.31M-3.71891News CoverageInsider TradeSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.9997 of 5 starsGBX 134.80-0.1%GBX 455+237.5%-16.5%£404.91M£521.32K-5.53300News CoverageHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416FARNFaron Pharmaceuticals OyN/AGBX 224.90+3.4%N/A+28.0%£301.93MN/A-6.0134VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap Up Related Companies and Tools Related Companies BTG Alternatives Abcam Alternatives Genus Alternatives Ergomed Alternatives Oxford Biomedica Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Faron Pharmaceuticals Oy Alternatives Verona Pharma plc (VRP.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ONT) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access